Rare metastasis of the urinary bladder from esophageal squamous cell carcinoma: a case report
BackgroundSquamous cell carcinoma (SCC) of the urinary bladder is rare, comprising less than 5% of all bladder cancers. There have been no previous reports of bladder SCC occurring as a metachronous metastatic tumor following curative resection for esophageal squamous carcinoma. This case report aim...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1515781/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850218194689589248 |
|---|---|
| author | Chunlei Zhang Dehui Chang Dongxing Wang Jiale Zuo Zhigang Cao |
| author_facet | Chunlei Zhang Dehui Chang Dongxing Wang Jiale Zuo Zhigang Cao |
| author_sort | Chunlei Zhang |
| collection | DOAJ |
| description | BackgroundSquamous cell carcinoma (SCC) of the urinary bladder is rare, comprising less than 5% of all bladder cancers. There have been no previous reports of bladder SCC occurring as a metachronous metastatic tumor following curative resection for esophageal squamous carcinoma. This case report aims to address the challenges in treatment strategy posed by such occurrences by presenting a case of esophageal SCC with subsequent bladder metastasis.Case descriptionThe patient is a 57-year-old Asian male with a 40-year history of heavy smoking. In July 2020, he was diagnosed with esophageal SCC, staged as cT2N1M0, and underwent radical surgery followed by adjuvant radiotherapy, chemotherapy, and immunotherapy. Post-surgery, he remained asymptomatic with regular check-ups showing no recurrence until November 2021, when he presented with hematuria. An MRU indicated a solid lesion in the bladder, and biopsy confirmed poorly differentiated SCC. A partial cystectomy was performed, followed by chemotherapy. Despite stable initial follow-ups, elevated CEA and SCC-Ag levels later suggested recurrence, confirmed by PET-CT and pathological examination showing lymph node metastases around the esophagus and in the neck. Subsequently, chemotherapy combined with immunotherapy was recommended.ConclusionFor solitary metachronous metastatic SCC of the bladder following esophageal SCC, surgical resection combined with postoperative adjuvant chemotherapy can be a viable treatment option. Partial cystectomy may be feasible for patients without lymphatic spread and who wish to preserve bladder function. Tumor markers CEA and SCC-Ag have proven effective in monitoring postoperative metastasis and can serve as reliable indicators for tumor follow-up. |
| format | Article |
| id | doaj-art-7b25482f20fd4cf483023dd4c2445b91 |
| institution | OA Journals |
| issn | 2234-943X |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj-art-7b25482f20fd4cf483023dd4c2445b912025-08-20T02:07:51ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-06-011510.3389/fonc.2025.15157811515781Rare metastasis of the urinary bladder from esophageal squamous cell carcinoma: a case reportChunlei Zhang0Dehui Chang1Dongxing Wang2Jiale Zuo3Zhigang Cao4Department of Urology, The 940 Hospital of Joint Logistics Support Force of Chinese People’s Liberation Amy (PLA), Lanzhou, Gansu, ChinaDepartment of Urology, The 940 Hospital of Joint Logistics Support Force of Chinese People’s Liberation Amy (PLA), Lanzhou, Gansu, ChinaDepartment of Urology, The 940 Hospital of Joint Logistics Support Force of Chinese People’s Liberation Amy (PLA), Lanzhou, Gansu, ChinaDepartment of Clinical Medicine, Lanzhou University Second Hospital, Lanzhou, Gansu, ChinaDepartment of Urology, The 940 Hospital of Joint Logistics Support Force of Chinese People’s Liberation Amy (PLA), Lanzhou, Gansu, ChinaBackgroundSquamous cell carcinoma (SCC) of the urinary bladder is rare, comprising less than 5% of all bladder cancers. There have been no previous reports of bladder SCC occurring as a metachronous metastatic tumor following curative resection for esophageal squamous carcinoma. This case report aims to address the challenges in treatment strategy posed by such occurrences by presenting a case of esophageal SCC with subsequent bladder metastasis.Case descriptionThe patient is a 57-year-old Asian male with a 40-year history of heavy smoking. In July 2020, he was diagnosed with esophageal SCC, staged as cT2N1M0, and underwent radical surgery followed by adjuvant radiotherapy, chemotherapy, and immunotherapy. Post-surgery, he remained asymptomatic with regular check-ups showing no recurrence until November 2021, when he presented with hematuria. An MRU indicated a solid lesion in the bladder, and biopsy confirmed poorly differentiated SCC. A partial cystectomy was performed, followed by chemotherapy. Despite stable initial follow-ups, elevated CEA and SCC-Ag levels later suggested recurrence, confirmed by PET-CT and pathological examination showing lymph node metastases around the esophagus and in the neck. Subsequently, chemotherapy combined with immunotherapy was recommended.ConclusionFor solitary metachronous metastatic SCC of the bladder following esophageal SCC, surgical resection combined with postoperative adjuvant chemotherapy can be a viable treatment option. Partial cystectomy may be feasible for patients without lymphatic spread and who wish to preserve bladder function. Tumor markers CEA and SCC-Ag have proven effective in monitoring postoperative metastasis and can serve as reliable indicators for tumor follow-up.https://www.frontiersin.org/articles/10.3389/fonc.2025.1515781/fullsquamous cell carcinomaesophagectomyurinary bladderbladder preservationtumor markers |
| spellingShingle | Chunlei Zhang Dehui Chang Dongxing Wang Jiale Zuo Zhigang Cao Rare metastasis of the urinary bladder from esophageal squamous cell carcinoma: a case report Frontiers in Oncology squamous cell carcinoma esophagectomy urinary bladder bladder preservation tumor markers |
| title | Rare metastasis of the urinary bladder from esophageal squamous cell carcinoma: a case report |
| title_full | Rare metastasis of the urinary bladder from esophageal squamous cell carcinoma: a case report |
| title_fullStr | Rare metastasis of the urinary bladder from esophageal squamous cell carcinoma: a case report |
| title_full_unstemmed | Rare metastasis of the urinary bladder from esophageal squamous cell carcinoma: a case report |
| title_short | Rare metastasis of the urinary bladder from esophageal squamous cell carcinoma: a case report |
| title_sort | rare metastasis of the urinary bladder from esophageal squamous cell carcinoma a case report |
| topic | squamous cell carcinoma esophagectomy urinary bladder bladder preservation tumor markers |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2025.1515781/full |
| work_keys_str_mv | AT chunleizhang raremetastasisoftheurinarybladderfromesophagealsquamouscellcarcinomaacasereport AT dehuichang raremetastasisoftheurinarybladderfromesophagealsquamouscellcarcinomaacasereport AT dongxingwang raremetastasisoftheurinarybladderfromesophagealsquamouscellcarcinomaacasereport AT jialezuo raremetastasisoftheurinarybladderfromesophagealsquamouscellcarcinomaacasereport AT zhigangcao raremetastasisoftheurinarybladderfromesophagealsquamouscellcarcinomaacasereport |